Evidence map›Paper›PMID 40470380›Full record

ReviewMedComm2025

Targeted Lung Premetastasis Niche: Mechanisms, Strategies, and Application.

Chenghao Cao, Di Lu, Huigang Li, Shen Pan, Jianyong Zhuo, Zuyuan Lin, Chiyu He, Peiru Zhang, Songmin Ying, Xuyong Wei and 3 more

Abstract readReview
In one paragraph

Review in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chenghao CaoZhejiang University School of Medicine Hangzhou China.
Di LuSchool of Clinical Medicine Hangzhou Medical College Hangzhou China.
Huigang LiZhejiang University School of Medicine Hangzhou China.
Shen PanZhejiang University School of Medicine Hangzhou China.
Jianyong ZhuoDepartment of Hepatobiliary and Pancreatic Surgery Hangzhou First People's Hospital Hangzhou China.
Zuyuan LinZhejiang University School of Medicine Hangzhou China.
Chiyu HeDepartment of Gastrointestinal Surgery The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China.
Peiru ZhangThe Fourth School of Clinical Medicine Zhejiang Chinese Medical University Hangzhou China.
Songmin YingDepartment of Respiratory and Critical Care Medicine Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou China.
Xuyong WeiDepartment of Hepatobiliary and Pancreatic Surgery Hangzhou First People's Hospital Hangzhou China.
Shusen ZhengDepartment of Hepatobiliary and Pancreatic Surgery Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province Shulan (Hangzhou) Hospital Shulan International Medical College Zhejiang Shuren University Hangzhou China.
Zhe YangDepartment of Hepatobiliary and Pancreatic Surgery Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province Shulan (Hangzhou) Hospital Shulan International Medical College Zhejiang Shuren University Hangzhou China.
Xiao XuSchool of Clinical Medicine Hangzhou Medical College Hangzhou China.ORCID https://orcid.org/0000-0002-2761-2811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung metastasis remains a leading cause of cancer mortality, driven not only by primary tumors but crucially by dynamic interactions within the premetastatic niche (PMN). Emerging evidence reveals that organ-specific PMN formation precedes tumor cell arrival, creating an immunosuppressive microenvironment conducive to metastatic colonization. Primary tumor-derived factors interact with lung resident cells, promoting the recruitment of bone marrow-derived cells and creating a favorable microenvironment for the migrating tumor cells. Despite progress, systematic integration of PMN's multilayered regulatory mechanisms-from mechanism to clinical application remains lacking. The review summarizes recent studies investigating the effects of PMN in the entire process of lung metastasis. Our discussion revolves primarily around extracellular vesicles, extracellular matrix remodeling, proinflammation, immunosuppression, angiogenesis, and metabolic reprogramming. We emphasize the impact of various treatment strategies for primary tumors on the PMN in clinical practice, while also summarizing current diagnostic methods and exploring new therapeutic possibilities in the PMN. Finally, we propose a roadmap for future investigations into the lung PMN, highlighting prioritized research axes that bridge mechanistic discoveries with bench-to-bedside translation of PMN-targeted interventions.

Indexed as

clinical implicationlung metastasispremetastatic nichetherapeutic strategytumor microenvironment

Identifiers

PMID40470380
PMCPMC12134401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.